50 related articles for article (PubMed ID: 16367937)
1. T-cell receptor tetramer binding or the lack there of does not necessitate antigen reactivity in T-cell receptor transduced T cells.
Lyons GE; Roszkowski JJ; Man S; Yee C; Kast WM; Nishimura MI
Cancer Immunol Immunother; 2006 Sep; 55(9):1142-50. PubMed ID: 16374636
[TBL] [Abstract][Full Text] [Related]
2. Non-viral precision T cell receptor replacement for personalized cell therapy.
Foy SP; Jacoby K; Bota DA; Hunter T; Pan Z; Stawiski E; Ma Y; Lu W; Peng S; Wang CL; Yuen B; Dalmas O; Heeringa K; Sennino B; Conroy A; Bethune MT; Mende I; White W; Kukreja M; Gunturu S; Humphrey E; Hussaini A; An D; Litterman AJ; Quach BB; Ng AHC; Lu Y; Smith C; Campbell KM; Anaya D; Skrdlant L; Huang EY; Mendoza V; Mathur J; Dengler L; Purandare B; Moot R; Yi MC; Funke R; Sibley A; Stallings-Schmitt T; Oh DY; Chmielowski B; Abedi M; Yuan Y; Sosman JA; Lee SM; Schoenfeld AJ; Baltimore D; Heath JR; Franzusoff A; Ribas A; Rao AV; Mandl SJ
Nature; 2023 Mar; 615(7953):687-696. PubMed ID: 36356599
[TBL] [Abstract][Full Text] [Related]
3. Production of retroviral constructs for effective transfer and expression of T-cell receptor genes using Golden Gate cloning.
Coren LV; Jain S; Trivett MT; Ohlen C; Ott DE
Biotechniques; 2015 Mar; 58(3):135-9. PubMed ID: 25757546
[TBL] [Abstract][Full Text] [Related]
4. Cell activation-based screening of natively paired human T cell receptor repertoires.
Fahad AS; Chung CY; López Acevedo SN; Boyle N; Madan B; Gutiérrez-González MF; Matus-Nicodemos R; Laflin AD; Ladi RR; Zhou J; Wolfe J; Llewellyn-Lacey S; Koup RA; Douek DC; Balfour HH; Price DA; DeKosky BJ
Sci Rep; 2023 May; 13(1):8011. PubMed ID: 37198258
[TBL] [Abstract][Full Text] [Related]
5. Tsyn-Seq: a T-cell Synapse-Based Antigen Identification Platform.
Jin Y; Miyama T; Brown A; Hayase T; Song X; Singh AK; Huang L; Flores II; McDaniel LK; Glover I; Halsey TM; Prasad R; Chapa V; Ahmed S; Zhang J; Rai K; Peterson CB; Lizee G; Karmouch J; Hayase E; Molldrem JJ; Chang CC; Tsai WB; Jenq RR
Cancer Immunol Res; 2024 May; 12(5):530-543. PubMed ID: 38363296
[TBL] [Abstract][Full Text] [Related]
6. Protocol for the detection of defined T cell clones in a heterogeneous cell population.
Gobbini A; Bandera A; Grifantini R; Abrignani S; Notarbartolo S
STAR Protoc; 2024 Mar; 5(1):102787. PubMed ID: 38141168
[TBL] [Abstract][Full Text] [Related]
7. Retroviral Transduction of Human Primary T Cells Followed by Real-Time T-Cell-Mediated Cancer Cell Cytolysis Analysis.
Rahbech A; Debets R; Thor Straten P; Peeters MJW
Methods Mol Biol; 2024; 2748():29-39. PubMed ID: 38070105
[TBL] [Abstract][Full Text] [Related]
8. T-cell receptor sequencing in interrogating antigen-specific T-cell responses to foreign and self-antigens.
Johansson AM; Kwok WW
J Allergy Clin Immunol; 2024 Jun; 153(6):1540-1542. PubMed ID: 38657797
[No Abstract] [Full Text] [Related]
9. Targeting cancers through TCR-peptide/MHC interactions.
He Q; Jiang X; Zhou X; Weng J
J Hematol Oncol; 2019 Dec; 12(1):139. PubMed ID: 31852498
[TBL] [Abstract][Full Text] [Related]
10. Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation.
Zilberberg J; Feinman R; Korngold R
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1000-7. PubMed ID: 25459643
[TBL] [Abstract][Full Text] [Related]
11. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.
Spaapen R; van den Oudenalder K; Ivanov R; Bloem A; Lokhorst H; Mutis T
Clin Cancer Res; 2007 Jul; 13(13):4009-15. PubMed ID: 17606735
[TBL] [Abstract][Full Text] [Related]
12. Rapid re-expression of retrovirally introduced versus endogenous TCRs in engineered T cells after antigen-specific stimulation.
van Loenen MM; Hagedoorn RS; de Boer R; van Egmond EH; Falkenburg JH; Heemskerk MH
J Immunother; 2011 Mar; 34(2):165-74. PubMed ID: 21304404
[TBL] [Abstract][Full Text] [Related]
13. T-cell receptor retrogenic mice: a rapid, flexible alternative to T-cell receptor transgenic mice.
Bettini ML; Bettini M; Vignali DA
Immunology; 2012 Jul; 136(3):265-72. PubMed ID: 22348644
[TBL] [Abstract][Full Text] [Related]
14. Redirecting cytotoxic T lymphocyte responses with T-cell receptor transgenes.
Clay TM; Morse M; Lyerly HK
Expert Opin Biol Ther; 2002 Apr; 2(4):353-60. PubMed ID: 11955274
[TBL] [Abstract][Full Text] [Related]
15. T cell receptor-transgenic primary T cells as a tool for discovery of leukaemia-associated antigens.
Ivanov R; Hol S; Aarts TI; Hagenbeek A; Ebeling SB
Clin Exp Immunol; 2006 Jan; 143(1):78-84. PubMed ID: 16367937
[TBL] [Abstract][Full Text] [Related]
16. HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity.
van der Veken LT; Hoogeboom M; de Paus RA; Willemze R; Falkenburg JH; Heemskerk MH
Gene Ther; 2005 Dec; 12(23):1686-95. PubMed ID: 16034453
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
